231 related articles for article (PubMed ID: 12409060)
21. Breast cancer chemoprevention.
Rosenbaum Smith SM; Osborne MP
Am J Surg; 2000 Oct; 180(4):249-51. PubMed ID: 11113429
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen debate hinges on whose risk is high enough.
Reynolds T
J Natl Cancer Inst; 1998 Oct; 90(19):1428-30. PubMed ID: 9776407
[No Abstract] [Full Text] [Related]
23. Effects of high dose raloxifene in selected patients with advanced breast carcinoma.
Gradishar W; Glusman J; Lu Y; Vogel C; Cohen FJ; Sledge GW
Cancer; 2000 May; 88(9):2047-53. PubMed ID: 10813716
[TBL] [Abstract][Full Text] [Related]
24. Status of antiestrogen breast cancer prevention trials.
Powles TJ
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):28-31. PubMed ID: 9556788
[TBL] [Abstract][Full Text] [Related]
25. Primary prevention of breast cancer: new approaches.
Cummings SR
Maturitas; 2007 May; 57(1):39-41. PubMed ID: 17391879
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer prevention.
Powles TJ
Oncologist; 2002; 7(1):60-4. PubMed ID: 11854547
[TBL] [Abstract][Full Text] [Related]
27. Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010.
Waters EA; McNeel TS; Stevens WM; Freedman AN
Breast Cancer Res Treat; 2012 Jul; 134(2):875-80. PubMed ID: 22622807
[TBL] [Abstract][Full Text] [Related]
28. Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR).
Runowicz CD; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Ford LG; Vogel VG; Wolmark N
Am J Obstet Gynecol; 2011 Dec; 205(6):535.e1-5. PubMed ID: 21872200
[TBL] [Abstract][Full Text] [Related]
29. Exemestane for primary prevention of breast cancer in postmenopausal women.
Zhang Y; Simondsen K; Kolesar JM
Am J Health Syst Pharm; 2012 Aug; 69(16):1384-8. PubMed ID: 22855103
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor as a target for the prevention of breast cancer.
Jordan VC
J Lab Clin Med; 1999 May; 133(5):408-14. PubMed ID: 10235123
[No Abstract] [Full Text] [Related]
31. Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.
Freedman AN; Yu B; Gail MH; Costantino JP; Graubard BI; Vogel VG; Anderson GL; McCaskill-Stevens W
J Clin Oncol; 2011 Jun; 29(17):2327-33. PubMed ID: 21537036
[TBL] [Abstract][Full Text] [Related]
32. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Narod S
J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863
[No Abstract] [Full Text] [Related]
33. Should you be taking tamoxifen?
Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691
[No Abstract] [Full Text] [Related]
34. Tamoxifen in cancer therapy: minireview.
Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer biology blossoms in the clinic.
Nass SJ; Hahm HA; Davidson NE
Nat Med; 1998 Jul; 4(7):761-2. PubMed ID: 9662357
[No Abstract] [Full Text] [Related]
36. Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.
Nelson HD; Smith ME; Griffin JC; Fu R
Ann Intern Med; 2013 Apr; 158(8):604-14. PubMed ID: 23588749
[TBL] [Abstract][Full Text] [Related]
37. Raloxifene, retinoids, and lavender: "me too" tamoxifen alternatives under study.
Ziegler J
J Natl Cancer Inst; 1996 Aug; 88(16):1100-2. PubMed ID: 8757185
[No Abstract] [Full Text] [Related]
38. Breast Cancer Prevention Trial shows major benefit, some risk.
Smigel K
J Natl Cancer Inst; 1998 May; 90(9):647-8. PubMed ID: 9586658
[No Abstract] [Full Text] [Related]
39. Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer.
Anderson C; Nichols HB; House M; Sandler DP
Cancer Prev Res (Phila); 2019 Nov; 12(11):801-808. PubMed ID: 31431499
[TBL] [Abstract][Full Text] [Related]
40. Tamoxifen vs the aromatase inhibitors: news from San Antonio, 2001.
Munster PN; Horton J
Cancer Control; 2001; 8(6):478-9. PubMed ID: 11807416
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
